Sharing poses a risk for transmission of blood-borne pathogens.

For example, 40-50 of the total daily insulin dose is to replace insulin overnight.

Your provider will prescribe an insulin dose regimen for you; however, you still need to calculate some of your insulin doses.

Your insulin dose regimen provides formulas that allow you to calculate how much bolus insulin to take at meals and snacks, or to correct high blood sugars.

In this section, you will find: First, some basic things to know about insulin: Approximately 40-50 of the total daily insulin dose is to replace insulin overnight, when you are fasting and between meals.

The other 50-60 of the total daily insulin dose is for carbohydrate coverage (food) and high blood sugar correction.

Bolus Carbohydrate coverage The bolus dose for food coverage is prescribed as an insulin to carbohydrate ratio.

The insulin to carbohydrate ratio represents how many grams of carbohydrate are covered or disposed of by 1 unit of insulin.

Generally, one unit of rapid-acting insulin will dispose of 12-15 grams of carbohydrate.

This range can vary from 6-30 grams or more of carbohydrate depending on an individuals sensitivity to insulin.

Insulin sensitivity can vary according to the time of day, from person to person, and is affected by physical activity and stress.

Bolus High blood sugar correction (also known as insulin sensitivity factor) The bolus dose for high blood sugar correction is defined as how much one unit of rapid-acting insulin will drop the blood sugar.

NovoLog Mix 7030 is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog Mix 7030 or one of its excipients.

Never Share a NovoLog Mix 7030 FlexPen Between Patients, even if the needle is changed.

Patients using NovoLog Mix 7030 vials must never share needles or syringes with another person.

Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia.

Changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased.

NovoLog Mix 7030 (insulin aspart protamine and insulin aspart injectable suspension) 100 UmL Indications and Usage NovoLog Mix 7030 (insulin aspart protamine and insulin aspart injectable suspension) 100 UmL is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in patients with diabetes mellitus.

NovoLog Mix 7030 is not recommended for the treatment of diabetic ketoacidosis.

The proportions of rapid-acting and long-acting insulins are fixed and do not allow for basal versus prandial dose adjustments.

Sliding Scale Aspart